by Dolly the Sheep | May 8, 2020 | CRISRP, Technology
History of RNAi In 1990, researchers noticed for the first time that RNA could potentially suppress gene expression in plants. The underlying mechanism of this “erratic and reversible” gene suppression was not clear. It wasn’t until almost a decade later...
by Dolly the Sheep | May 5, 2020 | COVID-19, Technology
BioGems is proud to offer a targeted portfolio of small molecules for life science research. Small molecules are low molecule weight organic compounds that affect key biological pathways to allow for the control of cellular responses. Their small size allows them to...
by Dolly the Sheep | Apr 28, 2020 | COVID-19, CRISRP, Technology
The COVID-19 pandemic has led to an urgent response from the research and scientific community around the world. The scientific community needs innovative tools that enable rapid development of COVID-19 diagnostics, therapeutics, and vaccines. Synthego is supporting...
by Dolly the Sheep | Apr 20, 2020 | Cancer, Immunology, Immunotherapy, in vivo Studies
Lymphocyte-activation gene 3 (LAG-3) is a receptor that negatively regulates the proliferation, activation, and effector function of T cells. Currently, monoclonal antibodies that block the interaction of LAG-3 with its canonical ligand, MHC-II, are being evaluated...
by Dolly the Sheep | Apr 14, 2020 | CRISRP
CRISPR is easily one of the most popular tools in modern biology. Since its introduction in 2012, CRISPR-based publications have increased about 30 fold. With NIH funding for CRISPR-related projects per year crossing a billion dollars in 2020, it is safe to assume...
